Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: J Neurooncol. 2015 Sep 18;126(3):385–393. doi: 10.1007/s11060-015-1939-2

Figure 2.

Figure 2

Radiation cooperates with PLX4720 to reduce S phase in BRAF V600E glioma cells. Bar graphs display distribution of cells within each cell cycle phase for GBM8 (BRAF WT) and AM-38 (BRAF V600E) treated with either radiation therapy (XRT; 6 Gy), PLX4720 (5 μM), PLX4720 + radiation (5 μM PLX4720 followed 24 hours later by 6 Gy radiation), or DMSO control. Cell cycle analyses were performed 24 hours after the last treatment. An arrow indicates S phase content.